» Articles » PMID: 28535153

High-energy Particle Beam and Gamma Radiation Exposure, Familial Relatedness and Cancer in Mice

Overview
Journal Br J Cancer
Specialty Oncology
Date 2017 May 24
PMID 28535153
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Some highly penetrant familial cancer syndromes exhibit elevated leukaemia risk, and there is evidence for familial clustering of lung cancer and other common cancers. Lung cancer and leukaemia are strongly radiogenic, but there are few indications that high-energy beam irradiation is markedly more effective than lower-energy radiation.

Methods: We used a Cox model with familially structured random effects to assess 16 mortality end points in a group of 1850 mice in 47 families maintained in a circular-breeding scheme, exposed to accelerated Si or Fe ions (0.4 Gy) or Cs gamma rays (3 Gy).

Results: There is periodicity in the effect of familial relatedness, which is most pronounced for pulmonary adenoma, Harderian-gland adenoma, Harderian-gland tumour, ectodermal tumour, pulmonary adenocarcinoma and hepatocellular carcinoma (P=0.0001/0.0003/0.0017/0.0035/0.0257/0.0340, respectively) with families that are 3-4 generations apart most strongly correlated; myeloid leukaemia also exhibited a striking periodic correlation structure. The relative risks of high-energy Si or Fe ions are not significantly different and are less than for Cs gamma-rays for most end points at the doses used.

Conclusions: There is periodicity in the effect of familial relatedness for various cancer sites. The effects per unit dose of high-energy charged particle beams are no higher than ninefold those of lower-energy gamma radiation.

Citing Articles

Radiation cataract in Heterogeneous Stock mice after γ-ray or HZE ion exposure.

Kleiman N, Edmondson E, Weil M, Fallgren C, King A, Schmidt C Life Sci Space Res (Amst). 2024; 40:97-105.

PMID: 38245354 PMC: 10800003. DOI: 10.1016/j.lssr.2023.09.004.


In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines.

Pantelic N, Bozic B, Zmejkovski B, Banjac N, Dojcinovic B, Wessjohann L Molecules. 2021; 26(11).

PMID: 34071809 PMC: 8198038. DOI: 10.3390/molecules26113199.

References
1.
Paganetti H . Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014; 59(22):R419-72. DOI: 10.1088/0031-9155/59/22/R419. View

2.
Little M, Schaeffer M, Reulen R, Abramson D, Stovall M, Weathers R . Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study. Br J Cancer. 2014; 110(10):2623-32. PMC: 4021527. DOI: 10.1038/bjc.2014.193. View

3.
Kendall G, Little M, Wakeford R, Bunch K, Miles J, Vincent T . A record-based case-control study of natural background radiation and the incidence of childhood leukaemia and other cancers in Great Britain during 1980-2006. Leukemia. 2012; 27(1):3-9. PMC: 3998763. DOI: 10.1038/leu.2012.151. View

4.
Nagy R, Sweet K, Eng C . Highly penetrant hereditary cancer syndromes. Oncogene. 2004; 23(38):6445-70. DOI: 10.1038/sj.onc.1207714. View

5.
Weil M, Bedford J, Bielefeldt-Ohmann H, Ray F, Genik P, Ehrhart E . Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1 GeV/nucleon (56)Fe ions. Radiat Res. 2009; 172(2):213-9. DOI: 10.1667/RR1648.1. View